AAAAAA

   
Results: 1-21 |
Results: 21
LEARNING ABOUT CLINICAL-TRIALS - THE WESTERN MULTICENTER, RANDOMIZED,DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL ON THE EFFECT OF CAFFEINE ON ALERTNESS AND CARDIOVASCULAR PARAMETERS
Authors: OSTBYE T PAUSE C MEISSNER O FEAGAN B BROWN JE STRASBERG HR DODGE J
Citation: T. Ostbye et al., LEARNING ABOUT CLINICAL-TRIALS - THE WESTERN MULTICENTER, RANDOMIZED,DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL ON THE EFFECT OF CAFFEINE ON ALERTNESS AND CARDIOVASCULAR PARAMETERS, Medical teacher, 20(2), 1998, pp. 127-132
ANTIBIOTICS ARE NOT EFFECTIVE THERAPY FOR CROHNS-DISEASE (TIME TO REMOVE THE ROSE-COLORED GLASSES)
Authors: FEAGAN B
Citation: B. Feagan, ANTIBIOTICS ARE NOT EFFECTIVE THERAPY FOR CROHNS-DISEASE (TIME TO REMOVE THE ROSE-COLORED GLASSES), Inflammatory bowel diseases, 3(4), 1997, pp. 314-317
ROLE OF THE ENTERIC MICROFLORA IN THE PATHOGENESIS OF INTESTINAL INFLAMMATION AND ARTHRITIS - DISCUSSION
Authors: HECHT G SARTOR RB FEAGAN B KRAEHENBUHL JP
Citation: G. Hecht et al., ROLE OF THE ENTERIC MICROFLORA IN THE PATHOGENESIS OF INTESTINAL INFLAMMATION AND ARTHRITIS - DISCUSSION, Alimentary pharmacology & therapeutics, 11, 1997, pp. 22-23
INTESTINAL PERMEABILITY IN CROHNS-DISEASE - DISCUSSION
Authors: SARTOR RB MEDDINGS J MAYER L KRAEHENBUHL JP BRANDTZAEG P JEWELL D BJARNASON L MADARA J FEAGAN B
Citation: Rb. Sartor et al., INTESTINAL PERMEABILITY IN CROHNS-DISEASE - DISCUSSION, Alimentary pharmacology & therapeutics, 11, 1997, pp. 53-56
HOW RELEVANT TO HUMAN INFLAMMATORY BOWEL-DISEASE ARE CURRENT ANIMAL-MODELS OF INTESTINAL INFLAMMATION - DISCUSSION
Authors: FEAGAN B SARTOR RB BRANDTZAEG P JEWELL D KRAEHENBUHL JP WRIGHT NA
Citation: B. Feagan et al., HOW RELEVANT TO HUMAN INFLAMMATORY BOWEL-DISEASE ARE CURRENT ANIMAL-MODELS OF INTESTINAL INFLAMMATION - DISCUSSION, Alimentary pharmacology & therapeutics, 11, 1997, pp. 96-97
DRUG DEVELOPMENT IN INFLAMMATORY BOWEL-DISEASE - BUDESONIDE - A MODELOF TARGETED THERAPY - DISCUSSION
Authors: MADARA J FEAGAN B BJARNASON I SARTOR RB BOUGHTONSMITH N
Citation: J. Madara et al., DRUG DEVELOPMENT IN INFLAMMATORY BOWEL-DISEASE - BUDESONIDE - A MODELOF TARGETED THERAPY - DISCUSSION, Alimentary pharmacology & therapeutics, 11, 1997, pp. 107-108
BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGED REMISSION IN CROHNS-DISEASE - A POOLED ANALYSIS
Authors: FEAGAN B GREENBERG GR LOFBERG R FERGUSON A PERSSON T
Citation: B. Feagan et al., BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGED REMISSION IN CROHNS-DISEASE - A POOLED ANALYSIS, Gut, 41, 1997, pp. 17-17
BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGS REMISSION IN CROHNS-DISEASE (CD) - A POOLED ANALYSIS
Authors: FEAGAN B GREENBERG GR LOFBERG R FERGUSON A PERSSON T
Citation: B. Feagan et al., BUDESONIDE CONTROLLED ILEAL RELEASE PROLONGS REMISSION IN CROHNS-DISEASE (CD) - A POOLED ANALYSIS, Gastroenterology, 112(4), 1997, pp. 970-970
IS UTILITY MEASUREMENT VALID IN CROHNS-DISEASE
Authors: FEAGAN B GREGOR J MCDONALD J LAMBA B KLAR N
Citation: B. Feagan et al., IS UTILITY MEASUREMENT VALID IN CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 970-970
WHICH QUALITY-OF-LIFE (QOL) MEASURE IS OPTIMAL FOR USE IN CLINICAL-TRIALS IN CROHNS-DISEASE (CD)
Authors: FEAGAN B GREGOR J MCDONALD J LAMBA B KLAR N
Citation: B. Feagan et al., WHICH QUALITY-OF-LIFE (QOL) MEASURE IS OPTIMAL FOR USE IN CLINICAL-TRIALS IN CROHNS-DISEASE (CD), Gastroenterology, 112(4), 1997, pp. 971-971
IS THE UTILITY ESTIMATION A USEFUL OUTCOME FOR CLINICAL-TRIALS IN CROHNS-DISEASE
Authors: GREGOR J FEAGAN B MCDONALD J LAMBA B KLAR N
Citation: J. Gregor et al., IS THE UTILITY ESTIMATION A USEFUL OUTCOME FOR CLINICAL-TRIALS IN CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 985-985
OCULAR COPPER DEPOSITION ASSOCIATED WITH BENIGN MONOCLONAL GAMMOPATHYAND HYPERCUPREMIA
Authors: PROBST LE HOFFMAN E CHERIAN MG YANG J FEAGAN B ADAMS P NICHOLS B
Citation: Le. Probst et al., OCULAR COPPER DEPOSITION ASSOCIATED WITH BENIGN MONOCLONAL GAMMOPATHYAND HYPERCUPREMIA, Cornea, 15(1), 1996, pp. 94-98
THE SHORT INFLAMMATORY BOWEL-DISEASE QUESTIONNAIRE - A QUALITY-OF-LIFE INSTRUMENT FOR COMMUNITY PHYSICIANS MANAGING INFLAMMATORY BOWEL-DISEASE
Authors: IRVINE EJ ZHOU Q THOMPSON AK ARCHAMBAULT A FEAGAN B FEDORAK R GROLL R LAUPACIS A MCDONALD JWD ROCHON J SAIBIL F VALBERG B GILLIES R RIDDELL R SEATON T SOMERS S DIRKS J FEUTREN G JEEJEEBHOY K SACKETT D DANDAVINO R GHENT CN GRYNOCH JR HOLBROOK AM KIBERD BA KNETEMAN N LEVINE M MANUEL M MUIRHEAD NN SAIPHOO CS SOMERVILLE PJ CAMERON L LOCKWOOD T SEGLENIEKS E TAYLORDOLMER K CHERRY R FISHER D KIRDEIKIS P MAHACHAI V SEDENS T SHERBANIUK R THOMSON A WENSEL R CASTELLI M COLLINS S CROITORU K CROWE S DONNELLY M GOODACRE R HUNT R LUMB B ROSSMAN R SALENA B STOSKOPF B BECK I DACOSTA L DAMORE D DEPEW W GROLL A HUDACIN J PATERSON W SIMON J ADAMS P ANDERSON B BARNETT W BELSHEIM M BENDY D EBERS W GILMORE P HOPKINS M HOWARD J LLOYD D PONICH T PROKOPIW I REYNOLDS R WATSON W ARONOFF A BLUM S CLELAND DP DALY D DAOUD H DAUPHINEE WD GORESKY C JABBARI M KATZ S KESSLER J KINNEAR D LICHTER M MILLS D MISHKIN S MLYNARYK P POLESKI M SZEGO P SZILAGYI A WILD G AUMAIS G COTE S COURTEAU MF DUBE S HEYEN F JOBIN G MARCHAND J MOUSSEAU R THIBERT F ANDREWS J COHEN L PEAREN S
Citation: Ej. Irvine et al., THE SHORT INFLAMMATORY BOWEL-DISEASE QUESTIONNAIRE - A QUALITY-OF-LIFE INSTRUMENT FOR COMMUNITY PHYSICIANS MANAGING INFLAMMATORY BOWEL-DISEASE, The American journal of gastroenterology, 91(8), 1996, pp. 1571-1578
ACCEPTANCE OF CYCLOSPORINE (CY) THERAPY FOR SEVERE ULCERATIVE-COLITIS(UC) AMONG CANADIAN GASTROENTEROLOGISTS
Authors: FEAGAN B MCDONALD JWD ROCHON J BOYLE E
Citation: B. Feagan et al., ACCEPTANCE OF CYCLOSPORINE (CY) THERAPY FOR SEVERE ULCERATIVE-COLITIS(UC) AMONG CANADIAN GASTROENTEROLOGISTS, Gastroenterology, 108(4), 1995, pp. 817-817
DEVELOPMENT OF A SEVERE ULCERATIVE-COLITIS (UC) INDEX
Authors: FEAGAN B MCDONALD WD ROCHON J BOYLE E HOPKINS M
Citation: B. Feagan et al., DEVELOPMENT OF A SEVERE ULCERATIVE-COLITIS (UC) INDEX, Gastroenterology, 108(4), 1995, pp. 817-817
DETECTION OF CAROTID STENOSIS BY PHYSICAL-EXAMINATION - REPLY
Authors: LAUPACIS A OSTBYE T FEAGAN B SACKETT DL SAUVE JS
Citation: A. Laupacis et al., DETECTION OF CAROTID STENOSIS BY PHYSICAL-EXAMINATION - REPLY, JAMA, the journal of the American Medical Association, 271(24), 1994, pp. 1908-1908
QUALITY-OF-LIFE - A VALID AND RELIABLE MEASURE OF THERAPEUTIC EFFICACY IN THE TREATMENT OF INFLAMMATORY DOWEL DISEASE
Authors: IRVINE EJ FEAGAN B ROCHON J ARCHAMBAULT A FEDORAK RN GROLL A KINNEAR D SAIBIL F MCDONALD JWD VALBERG B LAUPACIS A RIDDELL R SEATON T SOMERS S DIRKS J FEUTREN G JEEJEEBHOY K SACKETT D DANDAVINO R GHENT CN GRYNOCH JR HOLBROOK AM KIBERD BA KNETEMAN N LEVINE M MANUEL M MUIRHEAD NN SAIPHOO CS SOMERVILLE PJ CAMERON L LOCKWOOD T SEGLENIEKS E TAYLORDOLMER K CHERRY R FISHER D KIRDEIKIS P MAHACHAI V SEDENS T SHERBANIUK R THOMSON A WENSEL R CASTELLI M COLLINS S CROITORU K CROWE S DONNELLY M GOODACRE R HUNT R LUMB B ROSSMAN R SALENA B STOSKOPF B BECK I DACOSTA L DAMORE D DEPEW W HUDACIN J PATERSON W SIMON J ADAMS P ANDERSON B BARNETT W BELSHEIM M BONDY D EBERS W GILMORE P HOPKINS M HOWARD J LLOYD D PONICH T PROKOPIW I REYNOLDS R WATSON W ARONOFF A BLUM S CLELAND P DALY D DAOUD H DAUPHINEE WD GORESKY C JABBARI M KATZ S KESSLER J LICHTER M MILLS D MISHKIN S MLYNARYK P POLESKI M SZEGO P SZILAGYI A WILD G AUMAIS G COTE S COURTEAU MF DUBE S HEYEN F JOBIN G MARCHAND J MOUSSEAU R THIBERT F ANDREWS J COHEN L PEAREN S
Citation: Ej. Irvine et al., QUALITY-OF-LIFE - A VALID AND RELIABLE MEASURE OF THERAPEUTIC EFFICACY IN THE TREATMENT OF INFLAMMATORY DOWEL DISEASE, Gastroenterology, 106(2), 1994, pp. 287-296
EFFECTIVENESS OF PERIOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ELECTIVE HIP-REPLACEMENT
Authors: LAUPACIS A FEAGAN B WONG C
Citation: A. Laupacis et al., EFFECTIVENESS OF PERIOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ELECTIVE HIP-REPLACEMENT, Lancet, 342(8867), 1993, pp. 378-378
EFFECTIVENESS OF PERIOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ELECTIVE HIP-REPLACEMENT
Authors: BAILEY W BOURNE R FEAGAN B GRAINGER R LAUPACIS A PHILLIPS T RORABECK C SHEARER G VONLEWENSKI M ARSENAULT N DEFOY L HEBERT P LAFLAMME G LEGAULY F PAIEMENT G DUNCAN C KEULEN G LANGFORD H RANGNO K STROMBERG D WADE J ARTHUR C MADER S GROSS M DAVEY R LEONDIDIS O PIRC L
Citation: W. Bailey et al., EFFECTIVENESS OF PERIOPERATIVE RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ELECTIVE HIP-REPLACEMENT, Lancet, 341(8855), 1993, pp. 1227-1232
DOES THIS PATIENT HAVE A CLINICALLY IMPORTANT CAROTID BRUIT
Authors: SAUVE JS LAUPACIS A OSTBYE T FEAGAN B SACKETT DL
Citation: Js. Sauve et al., DOES THIS PATIENT HAVE A CLINICALLY IMPORTANT CAROTID BRUIT, JAMA, the journal of the American Medical Association, 270(23), 1993, pp. 2843-2845
PREDICTORS OF SURGERY IN CROHNS-DISEASE - A PROSPECTIVE EVALUATION
Authors: FEAGAN B ARCHAMBAULT A BOYLE E FEDORAK R GROLL A IRVINE EJ KINNEAR D LAUPACIS A MCDONALD JWD ROCHON J SAIBIL F VALBERG B
Citation: B. Feagan et al., PREDICTORS OF SURGERY IN CROHNS-DISEASE - A PROSPECTIVE EVALUATION, Gastroenterology, 104(4), 1993, pp. 699-699
Risultati: 1-21 |